awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38199797-31D9881C-3C0A-4BE5-879A-A7191D6D5855
Q38199797-31D9881C-3C0A-4BE5-879A-A7191D6D5855
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199797-31D9881C-3C0A-4BE5-879A-A7191D6D5855
Controversies in the management of gastrointestinal stromal tumors.
P2860
Q38199797-31D9881C-3C0A-4BE5-879A-A7191D6D5855
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199797-31D9881C-3C0A-4BE5-879A-A7191D6D5855
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a551ede42e91696f2793fd508d517b0346bd91f
P2860
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.